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Structures of the Ets Protein DNA-binding Domains of
Transcription Factors Etv1, Etv4, Etv5, and Fev
DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND
FORMATION*
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Background: Transcription factors of the Ets family regulate development and cancer.
Results:We show the details of DNA sequence recognition and identify structural changes that drastically affect DNA binding.
Conclusion: The activity of Ets transcription factors is regulated by their oxidation state.
Significance: Ets transcription factors may control the response of cells to oxygen levels.
Ets transcription factors, which share the conserved Ets DNA-
binding domain, number nearly 30 members in humans and are
particularly involved in developmental processes. Their deregula-
tion following changes in expression, transcriptional activity, or by
chromosomal translocation plays a critical role in carcinogenesis.
Ets DNAbinding, selectivity, and regulation have been extensively
studied; however, questions still arise regarding binding specificity
outside thecoreGGArecognitionsequenceandthemodeofaction
of Ets post-translationalmodifications. Here, we report the crystal
structures of Etv1, Etv4, Etv5, and Fev, alone and in complex with
DNA.We identifypreviouslyunrecognized featuresof theprotein-
DNA interface. Interactions with the DNA backbone account for
most of the binding affinity.Wedescribe a highly coordinatednet-
work of water molecules acting in base selection upstream of the
GGAA core and the structural features that may account for dis-
crimination against methylated cytidine residues. Unexpectedly,
all proteins crystallized as disulfide-linked dimers, exhibiting a
novel interface (distant to the DNA recognition helix). Homo-
dimersofEtv1,Etv4,andEtv5couldbereducedtomonomers, lead-
ing to a 40–200-fold increase in DNA binding affinity. Hence, we
present the first indicationof a redox-dependent regulatorymech-
anism that may control the activity of this subset of oncogenic Ets
transcription factors.
The Ets transcription factor family consists of 28 genes in
humans (1, 2) containing the evolutionarily conserved 85
amino acid Ets DNA-binding domain (3), originally identified
as a viral oncogene (E26 transformation-specific) (4). Ets pro-
teins exhibit ubiquitous or tissue-specific expression (5) and are
particularly involved in differentiation processes and the
response to signaling pathways (6, 7). Ets proteins may be clas-
sified based on the presence of additional structured domains
(5). The small PEA3 subfamily is characterized by an N-termi-
nal transactivation domain and consists of threemembers, Etv1
(Ets translocation variant 1, ER81), Etv4 (PEA3), and Etv5
(ERM) (8).
PEA3 transcription factors have roles in morphogenesis (9)
and neuronal differentiation (10, 11). PEA3 members are also
oncoproteins (8), whose overexpression correlateswith up-reg-
ulation of HER2/Neu and with progression in breast tumors
(12). ETV1 is amplified in 40% of melanomas (13), and over-
expression following chromosomal translocation of either ERG
or Etv1 to the androgen-inducible TMPRSS2 promoter is pres-
ent in most prostate tumors (14). Etv1 directly interacts with
the androgen receptor (15) and drives the androgen receptor
transcriptional response associated with aggressive prostate
cancer (16). Etv1 target genes include hTERT (17) and matrix
metalloproteinases (18) that maymediate cancer development.
Furthermore, Etv1 may be subverted by other oncoproteins
such as mutated (activated) KIT, which cooperates with ele-
vated Etv1 levels to promote tumorigenesis (19). Etv4 and Etv5
also play roles in morphogenesis, fertility, and oncogenesis (8).
Ewing’s sarcomas result from chromosomal translocations that
generate dominant transforming fusion proteins of the trans-
activation domain of the EWS protein with the ETS domain of
one of the five Ets proteins Etv1, Etv4, Erg, Fli1, and Fev (Fifth
Ewing Variant, PET-1) (20, 21). Fev lacks additional domains
and has a restricted tissue expression (21, 22). Fev regulates
serotonergic neuronal differentiation, being critical for normal
anxiety/aggression development (23), although overexpression
is associated with serotonin production in small intestine neu-
roendocrine tumors, stimulating tumor growth (24). Ets
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domains are thus a central nexus in tumor development and
disease progression. Targeting transcriptional regulation in
cancer with drugs is expected to be challenging (25), but Ets
inhibitors have been developed. YK-4-279 targets EWS-FLI1,
inhibits growth in Ewing sarcoma (26), and also inhibits Erg/
Etv1-driven prostate cancer invasion (27). Although this may
be useful for generic treatment of Ets-driven cancers, the lack of
specificity could cause off-target effects with other Ets proteins,
highlighting the need for further high resolution structural and
biochemical studies of Ets proteins.
The Ets domain is a variant helix-turn-helix (winged helix)
structure (28–31), comprising three -helices and a four-
stranded antiparallel -sheet. Ets domains bind to the EBS5
(Ets-binding site) in dsDNA with the 3 helix inserted into the
major groove, and invariant arginine and tyrosine residues
hydrogen bonded to bases of the invariant 5-GGA(A/T)-3
sequence in the EBS (2). Although binding the GGA(A/T) core
is a common property of Ets transcription factors, a genome-
wide analysis of all Ets family members has established that Ets
domains recognize up to nine bases (32) (three upstream and
two downstreamof theGGA(A/T) core), and they are classified
into four distinct classes based on the sequence preferences for
these flanking regions. Etv1, Etv4, Etv5, and Fev all belong to the
large and diverse class I (containing 14 of 26 of the mammalian
Ets transcription factors), which recognize a consensus
sequence ACCGGAAGT(G/A). The structural basis for this
sequence discrimination is unclear, as there are no direct base
contacts outside of the core. Indirect readoutmechanisms have
been suggested, based on sequence-dependent DNA confor-
mational preferences (33). However, no mechanism for how
sequence preferences would influence shape readout has been
proposed nor how the different classes of Ets domains achieve
their observed sequence specificities outside the GGA within
this paradigm.
A number of other factors influence Ets DNA binding,
including interaction with other transcription factors to recog-
nize combined operators in a cooperativemanner (34), cooper-
ative binding of palindromic sequences by dimerization (35),
and the presence of auto-inhibitory regions surrounding the Ets
domain (36–38). DNA binding is also subject to post-transla-
tional regulation (39) with protein kinase A phosphorylation of
Etv1 at Ser-334 (40) and the equivalent Ser-367 in Etv5 (41)
repressing DNA binding. Several Ets proteins have been iden-
tified as being subject to redox control, with redox-sensitive
cysteines present in GA-binding protein  (GABP) affecting
dimerization and DNA binding (42). However, as with the case
for phosphorylation, the structural mechanism for this regula-
tion is unclear.
Additional regulation of Ets DNA binding may occur at the
DNA level, with several Ets motifs being over-represented in
methylated genomic regions (43). Some Ets proteins are known
to bind to their cognate sequence in vitro and in vivo only in a
demethylated state, including GABP (44, 45) and ETS1 (46).
Directmethylation of the class I EBS sequence is possible in two
positions (CmGGAA/TTCCmG); however, it is not known
whether and to what extent this direct methylation affects Ets
binding.
Here, we present the crystal structures of the Ets domains of
the entire PEA3 subfamily (Etv1, Etv4, and Etv5) together with
the structure of the Erg familymember (Fev). All proteins share
a highly conserved core Ets structure andmake extensive inter-
actions with DNA. Comparisons of apo- and DNA-bound
forms of Etv1, Etv4, and Fev allow us to identify residue move-
ments and disorder to order transitions that occur upon DNA
binding. In theDNAcomplex structures of Etv5 and Fev (which
are determined to 1.9 and 2.0 Å resolution, respectively), we
observe a network of coordinatedwatermolecules contributing
to sequence recognition upstream to the GGA core. Structural
and biochemical analysis of Etv1 clarifies mechanisms of
post-translational regulation in Ets proteins, including PKA-
mediated phosphorylation at Ser-334 and the abrogation of
Ets binding to sites that include a methylated CpG. Further-
more, a new Ets dimerization interface linked by a redox-sen-
sitive disulfide bond is identified, and this dimerization is
shown to result in a significant inhibition of DNA binding,
potentially linking Ets transcription factors with cellular redox
regulatory mechanisms.
Experimental Procedures
Cloning and Site-directed Mutagenesis—Plasmid DNA tem-
plates for full-length Etv1, Etv4, Etv5, and Fev were obtained
from theMammalianGene Collection (I.M.A.G.E. Consortium
Clone IDs 30345383, 3854349, 3050350, and 4130242, respec-
tively) (47). Regions corresponding to the core Ets domains
were amplified by PCR using Pfx DNA polymerase (Invitrogen,
Paisley, UK). PCR products were ligation independent cloning
into the pNIC28-Bsa4 expression vector (GenBankTM acces-
sion number EF198106, encompassing a tobacco etch virus
(TEV)-cleavable (shown by *) N-terminal His6 tag MHHH-
HHHSSGVDLGTENLYFQ*SM), as described elsewhere (48).
The initial Etv1 construct contained two primer-incorporated
mutations (Y329S and P427S) and thus were designated
Etv1Y329S-P427S. A subsequent construct containing the wild-
type sequence is referred to as Etv1. Additional mutants were
generated in a full-length Etv1 construct using the megaprimer
method (49). The Gly-326–Asn-429 fragments of the Etv1
mutant derivatives were then subcloned for bacterial expres-
sion into pNIC28-Bsa4 as described and confirmed by sequenc-
ing. Expression plasmids were transformed into BL21 (DE3)
Rosetta-R3 (48) or, when indicated, into Rosetta-gamiTM 2
(Novagen).
Recombinant Protein Expression—Recombinant protein expres-
sion was induced by the addition of 0.1 mM isopropyl 1-thio--
D-galactopyranoside to bacterial cultures grown in TB (Terrific
Broth) containing 50 g/ml kanamycin at an OD600 of 3.0 at
37 °C in UltraYield baffled flasks (Thomson Instrument Co,
Oceanside, CA). Cultures were further incubated at 18 °C over-
night. Selenomethionine-derivatized Etv1Y329S-P427S expres-
sion was performed at 37 °C in M9 minimal medium, supple-
mented with 0.4% glucose, 2 mMMgSO4, 0.1 mMCaCl2, and 50
5 The abbreviations used are: EBS, Ets-binding site; 5meC, 5-methylcytosine;
TCEP, tris(2-carboxyethyl)phosphine; BisTris, 2-[bis(2-hydroxyethyl)ami-
no]-2-(hydroxymethyl)propane-1,3-diol; MWCO, molecular weight cutoff;
CV, column volume; PDB, Protein Data Bank; SEC, size exclusion chroma-
tography; TEV, tobacco etch virus; GABP, GA-binding protein .
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g/ml kanamycin. Cellswere cultured to anOD600 of 0.8 and 25
g/ml selenomethionine was added, along with leucine, isoleu-
cine, and valine to 50 g/ml, and lysine, threonine, and phenyl-
alanine to 100 g/ml. Cultures were further incubated until
OD600 of 1.2, and protein expressionwas induced by addition of
isopropyl 1-thio--D-galactopyranoside and selenomethionine
to final concentrations of 0.1 mM and of 75 g/ml, respectively.
Cells were harvested after further overnight incubation at 18 °C
and stored at 80 °C.
Protein Purification—For purification of Etv1, Etv4, Etv5, and
Fev constructs, 50 g of cell pellets were thawed and resus-
pended in buffer A (50 mM HEPES, pH 7.5, 500 mM NaCl, 5%
glycerol, 10 mM imidazole, 0.5 mM tris(2-carboxyethyl)phos-
phine (TCEP)), with the addition of 1 protease inhibitor set
VII (Merck, Darmstadt, Germany) and 15 units/ml Benzonase
(Merck). Cells were lysed using sonication. Cell debris and
nucleic acids were removed by addition of 0.15% polyethylene-
imine, pH 7.5, and centrifugation at 40,000  g for 1 h at 4 °C.
Clarified lysates were applied to a 3-ml Ni2-iminodiacetic
acid-immobilized metal ion affinity chromatography gravity
flow column (Generon, Maidenhead, UK), washed with 20 col-
umn volumes (CV) of buffer A, followed by 20 CV of wash
buffer (buffer A with 30 mM imidazole). Fractions were eluted
with 5 2-CV aliquots of buffer A containing 300 mM imidaz-
ole and analyzed by SDS-PAGE, and relevant fractions pooled
and cleaved with His6-tagged TEV protease (1:20 mass ratio)
overnight at 8 °C. Imidazole was removed by concurrent dialy-
sis during cleavage, using a 3.5-kDa MWCO snakeskin mem-
brane (Thermo Fisher Scientific, Rockford, IL) in buffer B (20
mMHEPES, pH 7.5, 500 mMNaCl, 5% glycerol, 0.5 mM TCEP).
TEV protease was removed from dialyzed proteins using Ni-
IDA immobilizedmetal ion affinity chromatography (2-ml CV)
and washed with an imidazole gradient in 20 mM steps to 100
mM in buffer B, and cleaved protein was pooled and concen-
trated with a 3-kDa MWCO centrifugal concentrators (Viva-
products, Littleton,MA). Final separationwas by size exclusion
chromatography, using a HiLoad 16/60 Superdex S75 or 200
column equilibrated in buffer B, and run at 1.2ml/min in buffer
B. Protein identity was confirmed by LC/ESI-TOF mass spec-
trometry. Protein concentrations were calculated from A280
(Nanodrop) using the calculatedmolecularmass and extinction
coefficients. The scheme was identical for purification of disul-
fide-linked proteins but with the omission of TCEP from all
buffers.
Crystallization and Structural Determination—The purified
Ets domains of Fev and Etv1 were crystallized with double-
stranded DNA as follows. Oligonucleotides for co-crystalliza-
tion were synthesized and used without further purification
(Eurofins MWG Operon, Ebersberg, Germany). The oligonu-
cleotides (5-ACCGGAAGTG-3) and (5-CACTTCCGGT-
3), with the Ets core recognition sequence underlined, were
annealed by mixing 450 M of each oligonucleotide in 10 mM
Tris, pH 7.5, 50 mMNaCl, heating to 95 °C for 5 min, and cool-
ing to 21 °C slowly in a heating block. Frozen Etv1Y329S-P427S or
Fev was thawed rapidly, and aggregates were removed by
microcentrifugation at 14,000  g for 10 min at 4 °C. To form
DNA complexes, proteins were mixed with annealed oligonu-
cleotides in a 1:1.1 molar ratio in a buffer consisting of 10 mM
HEPES, 166mMNaCl, 5% glycerol, and 0.5mMTCEP at protein
concentrations of 5.3 and 6 mg/ml, respectively, and incubated
on ice for30min. The protein/DNAmixtures were then con-
centrated by ultrafiltration using a 3000-DaMWCOcentrifugal
concentrator to an estimated protein concentration of 12.5 and
16 mg/ml for Etv1-DNA and Fev-DNA, respectively. For crys-
tallization of the Etv4 and Etv5 DNA complexes, the same pro-
cedure was repeated but using the oligonucleotides (5-ACCG-
GAAGTG-3) and (5ACTTCCGGTC3). In all cases, sitting
drop vapor diffusion crystallization trials were set up with a
Mosquito (TTP Labtech) crystallization robot. Crystals were
obtained in the following conditions: Etv1 (16 mg/ml, 20 °C),
2.5 M sodium formate; Etv-1 DNA (12 mg/ml, 4 °C), 28% PEG
smear low molecular weight, 0.2 M sodium chloride, 0.1 M Tris,
pH 8.5, 5% glycerol; SeMet-Etv1-DNA (15 mg/ml, 4 °C), 20%
PEG3350, 0.2M potassiumcitrate; Etv4 (16mg/ml, 20 °C), 0.8M
sodium citrate tribasic, 0.1M cacodylate, pH 6.5; Etv4-DNA (10
mg/ml, 20 °C), 20% PEG 3350, 0.2Mmagnesium chloride, 0.1M
BisTris, pH 5.5; Etv5-DNA (8 mg/ml, 20 °C), 40% PEG 300, 0.2
M calcium acetate, 0.1 M cacodylate, pH 6.0; Fev (18 mg/ml,
4 °C), 0.8 M sodium citrate tribasic, 0.1 M cacodylate, pH 6.5;
Fev-DNA (16 mg/ml, 20 °C), 25% PEG 3350, 0.1 M BisTris,
pH 5.5.
Crystals were cryo-protected by transferring the crystal to a
solution ofmother liquor supplemented with 25% ethylene gly-
col and flash-cooling in liquid nitrogen. Datasets were collected
for all crystals at Diamond Light source beamlines I04 (Etv1,
Etv1-DNA, and Fev-DNA), I02 (Fev), I24 (Etv4-DNA), and I03
(Etv4, Etv5-DNA and selenomethionine Etv1-DNA). Diffrac-
tion data were processed with the programs autoPROC (Etv1
and Etv1-DNA) (50), MOSFLM (Fev) (51), and XDS (Etv4,
Etv4-DNA, Etv5-DNA and Fev-DNA) (52). The structures of
Etv1, Etv4, Etv4-DNA, Etv5-DNA, Fev, and Fev-DNA were
solved by molecular replacement using the program PHASER
(53). Initial attempts to solve the Etv1-DNA complex bymolec-
ular replacement were unsuccessful, and for this reason, the
selenomethionine-derivatized protein was produced, and SAD
data were collected close to the selenium peak wavelength
(0.976 Å). Selenium atom positions were located with the pro-
gram SHELX (54) and refined using the program SHARP (55).
Model building and manipulation were performed in COOT
(56), and the structures were refined using autoBUSTER
(Global Phasing) (Etv1, Etv1-DNA, and Fev), REFMAC (Etv4)
(57), and PHENIX REFINE (Etv4-DNA, Etv5-DNA and Fev-
DNA) (58). A summary of the crystallization conditions, data
processing, phasing, and refinement statistics for all datasets
are shown in Tables 1 and 2.
LC/ESI-TOF Mass Spectrometry of Intact Proteins—30-l
protein samples at 0.02mg/ml in 0.1% formic acidwere injected
onto a 4.6  50 mm Zorbax 5-m 300SB-C3 column and
resolved by reversed-phase chromatography at 40 °C. The sol-
vent system was 0.1% formic acid in double distilled H2O
(buffer A) and 0.1% formic acid in methanol (buffer B), with 1
min at 5% buffer B and then a linear gradient of 5–95% buffer B
over 6 min at 0.5 ml/min. Protein intact mass was determined
using an MSD-TOF electrospray ionization orthogonal time-
of-flight mass spectrometer (Agilent Technologies, Palo Alto,
CA) operated in positive ion mode.
Structures and Redox Regulation of Etv and Fev
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In Vitro Protein Phosphorylation—Phosphorylation of Etv1
Ser-334 by protein kinase A was performed in vitro using 2.5
units of bovine heart PKA catalytic subunit (P2645, Sigma)with
40 g of Etv1, in modified buffer B (20 mMHEPES, pH 7.5, 500
mM NaCl, 5% glycerol, 1 mM ATP, 10 mM MgCl2, and 5 mM
dithiothreitol). Reactions were performed for 4 h at room tem-
perature and quenched by the addition of 50 mM EDTA, fol-
lowed by buffer exchange into buffer B with Micro Bio-Spin
P-6 columns (Bio-Rad) and confirmation of phosphorylation by
ESI-TOF mass spectrometry of the intact protein.
Electrophoretic Mobility Shift Assays—Equilibrium binding
constants (Kd) of Ets constructs were estimated by EMSA.
Unless otherwise specified, the dsDNA probe contained the
single consensus Ets-binding site used in crystallization (under-
lined), with oligonucleotides Etv1ALF (5-ATCTCACCGGA-
AGTGTAGCA-3) and Etv1ALR (5-TGCTACACTTCCGG-
TGAGAT-3). Substrates were prepared by 32P-end-labeling
one oligonucleotide, annealing to the complementary strand in
10 mM Tris-Cl, pH 7.5, 50 mM NaCl, prior to purification with
Micro Bio-Spin P-6 columns. Proteins were generally titrated
from 1014 to 106 M. The DNA probe was used at 2 nM for the
initial estimations ofKd (termedKd
app1 in Table 3). As the disso-
ciation constants of wild-type Etv1 were estimated to be sub-
nanomolar, we repeated some of the measurements with a DNA
probe concentration of 0.1 nM to maintain an excess of protein
(results listed asKd
app2 in Table 3). As seen in Table 3, the effects
of mutations are qualitatively similar at both DNA concentrat-
ions. EMSA buffer is composed of 50 mM Tris-HCl, pH 7.5, 50
mM NaCl, 2 mM MgCl2, 0.01% Tween 20, and 5% glycerol.
Proteins were reduced with 10 mM TCEP prior to assay unless
otherwise specified. Reactions were performed for 1 h at room
temperature, prior to mixing with loading dye to 0.25%, and
resolved by 10% native PAGE at 150 V for 1 h at room temper-
ature. Gels were analyzed using phosphorimaging, and the
apparent Kd value was estimated from plots by nonlinear
regression with a least squares fit, using a specific one-site
TABLE 1
Data collection and refinement statistics for DNA free structures
Values in parentheses are for the highest resolution shell.
 Rmerge  	hkl	iIi  Im/	hkl	iIi, where Ii and Im are the observed intensity and mean intensity of related reflections, respectively.
* Rp.i.m.  	hkl√(1/n  1) 	in  1Ii  Im/	hkl	i Ii.
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binding model with Hill slope (Prism, GraphPad, San Diego).
Other EMSA substrates are described in the respective figure
legends.
Results
DNA-free Structures of the Ets Domains of Etv1, Etv4, and
Fev—The full-length sequences of Etv1, Etv4, Etv5, and Fev are
predicted to include disordered regions, which often hinder
crystallization. We have generated several expression con-
structs, including the full-length and truncated versions of each
protein. Crystals were obtained from constructs that contained
the Ets domain, Etv1 (encompassing amino acids 326–429),
Etv4 (encompassing amino acids 338–470), and Fev (encom-
passing amino acids 42–141). The construct of Etv1 included
two inadvertent mutations that resulted from primer impuri-
ties as follows: Y329S at the N terminus, and P427S at the C
terminus; this construct is denoted Etv1Y329S-P427S. Our at-
tempts to crystallize the corresponding constructwith thewild-
type sequence failed, although the mutated residues are in dis-
ordered regions or at the end of the ordered region of the crystal
structures of Etv1, so they are unlikely to have any bearing on
the structural and functional analyses. We have also attempted
to crystallize Etv5 using a similar construct strategy to that
defined above (Etv5 construct encompassing amino acids 365–
462), but despite obtaining protein of similar purity and yield as
the other Etv constructs, we were unable to grow crystals of
Etv5 in the absence of DNA.
Crystals of Etv1Y329S-P427S diffracted to 1.82 Å and contained
four copies of Etv1 in the asymmetric unit (4AVP, Tables 1 and
2). Electron density is observed for residues Ser-334 to Phe-426
(thus excluding the Y329S and P427S mutations) with most
side chains visible. Etv4 crystals diffracted to 1.05 Å and con-
tained a single copy of Etv4 in the asymmetric unit (4CO8,
Tables 1 and 2). Fev crystals diffracted to 2.64 Å, with two cop-
ies of Fev per asymmetric unit (2YPR, Tables 1 and 2). Ets
domains are highly similar in sequence (Fig. 1A), with Etv1,
TABLE 2
Data collection and refinement statistics for DNA complexes
Values in parentheses are for the highest resolution shell.
 Rmerge  	hkl	iIi  Im/	hkl	iIi, where Ii and Im are the observed intensity and mean intensity of related reflections, respectively.
* Rp.i.m.  	hkl√(1/n  1) 	in  1Ii  Im/	hkl	i Ii.
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Etv4, andEtv5 all sharing over 90% sequence identities, whereas
Fev is slightly more distantly related (65% identity).
In the structural descriptions that follow, the protein resi-
dues are numbered according to their position in Etv1; a list of
the corresponding residues in Etv4 andEtv5 andFev is provided
in Table 4.
Etv1, Etv4, and Fev display the typical fold of the Ets domain
(Fig. 1,B andC), which contains three-helices (1–3) flanking
a four-stranded -sheet, with an additional C-terminal helix
(4). The structures are highly similar (typical root mean
square deviation of 1.0 Å over 90 residues), with the main
difference being a two-amino acid deletion in Fev (Fig. 1A),
linked to a shift of 30° in the orientation of the C-terminal 4
helix in the Fev structure compared with the other structures
(Fig. 1C). Superposition of the main chains of other Ets domain
structures reveals considerable heterogeneity in the region cor-
responding to helix 4 (Fig. 1D). This region was not expected
to be helical from proline-scanning mutagenesis (59) and was
not structured in the NMR ensemble of the closest structural
homologue of Fev, Fli1 (31).
Crystal Structure of the Etv1, Etv4, Etv5, and Fev DNA
Complexes—Both Etv1 and Fev DNA complexes were crystal-
lized using a single 10-base pair DNA duplex containing the
class I consensus EBS sequence. Etv4 and Etv5 DNA complexes
were crystallized using oligonucleotide duplexes that had nine
complementary base pairs (containing the same consensus
sequence) with a single overhanging nucleotide on each end,
which makes favorable interactions with neighboring DNA
molecules (Fig. 2A). Etv1-DNA crystals diffracted to 2.9 Å and
contained a single copy of Etv1 and a single DNA duplex in the
asymmetric unit (4BNC,Table 2). Etv4-DNAcrystals diffracted
to 2.8 Å resolution and contained eight Etv4 molecules and
eight DNA duplexes in the asymmetric unit (4UUV, Table 2),
with the only significant differences between the various chains
in the asymmetric unit being the chemical environment of the
DNA chains. Etv5-DNA crystals diffracted to 1.95 Å and con-
tained a single copy of Etv5, a single calcium ion (bound close to
the N terminus of 4), and a single DNA duplex in the asym-
metric unit (4UN0, Tables 1 and 2). Fev-DNA crystals dif-
fracted to 2.64 Å, with two copies of Fev per asymmetric unit
(2YPR, Tables 1 and 2). In all the DNA complex crystals, base
pair stacking interactions between neighboring molecules
allow theDNA to form a pseudo-contiguous helix that, in some
cases, runs the entire length of the crystal (Fig. 2A).
In all four DNA complexes, the recognition helix (3)
inserts deep into the major groove and provides multiple
contacts with the base pairs of the core GGAA sequence, as
well as with the phosphate backbone (Fig. 2, B and C). Addi-
tional contacts to the DNA backbone are provided by the C
terminus of 2, the 2-3 loop, 3, and the 3-4 loop. The
proteins contact the DNA over a span of 9 bp, and the interface
accounts for the burying of 9% (500 Å2) of the total solvent-
accessible surface area. To accommodate these extensive inter-
faces, the DNA becomes slightly distorted from the canonical B
form, exhibiting smooth bending of 20° toward the protein
with significant widening of the major groove (20.5 Å at wid-
est point) in the vicinity of the recognition helix and narrowing
of the minor groove downstream (9.3 Å at narrowest point)
(Fig. 2D). The bending of theDNAcan be explained by the large
number of contacts made to the phosphodiester backbone,
many of which are charged in nature possibly introducing
bending through asymmetric phosphate neutralization (60).
Specifically in Etv1, hydrogen bonds to phosphate oxygens are
formed with the side chains of residues Gln-336, Trp-375, Tyr-
386, Ser-392, andTyr-396, whereas salt bridges are formedwith
Lys-379, Lys-388, Lys-399, and Lys-404 (Fig. 2C). Two addi-
tional charged residues, Arg-381 and Arg-409, appear to be in
position with the potential to interact with the phosphodiester
backbone; the former occupies a position between the two
DNA strands in the region of the minor groove narrowing, and
TABLE 3
DNA binding affinity of Ets domain constructs (Etv1 unless specified)
NA indicates undetectable binding or below threshold for regression analysis.Kd
app1 indicates apparentKd valuemeasured with a 2 nMDNA probe.Kd
app2 indicates apparent
Kd value measured with a 0.1 nM DNA probe.
Construct
(Etv1 unless specified otherwise) Description/mutation K
d
app1 (1010 M)a
K
d
app1-fold
inhibitionb K
d
app2 ( 1010 M)a
K
d
app2-fold
inhibitionb
WT Wild type Ets domain 2.7 
 0.28 1 5.9 
 1.5 1
Y329S-P427S PCR mutant Ets domain 2.5 
 0.26 0.9 3.1 
 0.6 0.5
K379A DNA backbone contact NA NA
D387A DNA base contact 1.7 
 0.2 0.6 1.9 
 0.3 0.3
R391A DNA base contact 118 
 14.8 43.7 86.0 
 16.8 14.6
R394A DNA base contact 2757 
 627 1021 ND ND
Y395F DNA base contact 2.3 
 0.5 0.9 13.5 
 10.5 2.3
Y396F DNA backbone contact 26390 
 9349 9774.1
Y397F DNA backbone contact NA NA
K404A DNA backbone contact NA NA
S334E Phosphoserine mimic 8.9 
 3.2 3.3 9.4 
 5.1 1.6
WT (phosphorylated) PKA-phosphorylated Ser-334 521 
 455 193
C416S Abrogation of disulfides 4.6 
 0.6 1.7 2.6 
 0.6 0.4
WT dimer Disulfide-linked dimeric WT ETV1 195 
 148 72.2 802 
 164 136
WT dimer (TCEP reduced) Dimeric WT ETV1, reduced 11.2 
 2.6 4.1 2.6 
 0.4 0.4
WT dimer (9:1 GSH:GSSG) Dimeric WT ETV1, reduced 171 
 23 29
WT dimer (1:9 GSH:GSSG) Dimeric WT ETV1, reduced 272 
 30 47
Etv4 WT (reduced) Wild type Ets domain, reduced 3.4 
 0.66 1
Etv4 WT (oxidized) Disulfide-linked dimeric WT ETV4 148 c 
 35 44
Etv5 WT (reduced) Wild type Ets, reduced 11.6 
 1.1 1
Etv5 WT (oxidized) Disulfide-linked dimeric WT ETV5 790 
 610c 68
a Kd 
 S.E.
b Fold increase in Kd value compared with the corresponding wild type.
c Estimated, due to binding at regression analysis threshold.
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the latter could potentially form an additional salt bridge in
longer DNA sequences. All of the equivalent interactions are
preserved in Etv4, Etv5, and Fev with the exception of Arg-381
and Ser-392, which are replaced by Lys-93 andAla-104, respec-
tively, in Fev.
Recognition of Specific DNA Substrates by Etv1 and Fev—The
Ets family of transcription factors display sequence-specific
DNA recognition for nine residues, which we have numbered
3 to6 around the invariant 5-GGA-3 core. This coreGGA
sequence is directly recognized in all Ets familymembers by two
arginines and a tyrosine (Arg-391, Arg-394, and Tyr-395 in
Etv1; Arg-103, Arg-106, and Tyr-107 in Fev), found invariably
on the recognition helix (3). The two arginine residues are
both positioned with their guanidinium groups directly above
theO6 andN7 of the two guanine bases and, due to the require-
ment for two hydrogen bond acceptors, are capable of direct
recognition of guanine at positions 1 and 2 (Fig. 3A). Similarly,
the tyrosine is in a position to accept a hydrogen bond from the
N6 of the adenine residues at position 3 (Fig. 3A); positioning of
the complementary thymine methyl group in a nonpolar envi-
FIGURE 1. Etv1 and Fev Ets domain topology and sequence alignment. A, sequence alignment of class I Ets domains. Sequences were Etv1 (AAD29877), Etv4
(AAH16623), Etv5 (CAG33048), GABP (NP_001184226), ETS1 (CAG47050), FLI1 (AAH10115), and Fev (NP_059991). Secondary structural assignment is for Etv1
(PDB code 4AVP), containing additional flanking residues where appropriate. Green, helix ( or 310); yellow, -strand; *, serine phosphorylated by protein kinase
A; , conserved cysteine involved in disulfide bond formation in Etv1, -4, and -5. B, overall cartoon representation of Etv1 Ets domain. Green, helix ( or 310);
yellow, -strand. C, superimposition of Etv1 (PDB code 4AVP, blue) and Fev (PDB code 2YPR, yellow). D, ribbon superimposition showing the variance in the
positions of 4. Structures used were Etv1 (PDB code 4AVP), Fev (PDB code 2YPR), ELF3 (PDB code 3JTG), ETS1 (PDB code 3MFK), Etv6 (PDB code 2LF7), GABP
(PDB code 1AWC), and ELK4 (PDB code 1BC8).
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ronment created by the aliphatic portion of the side chains of
Arg-391 (Fev-Arg-103) and Lys-388 (Fev-Lys-100) may also
contribute to recognition at this position. The characteristic
positioning of the two arginine side chains is likely to be further
stabilized by cation- stacking interactions, which, in the case
of Ets domains, form between the guanidinium group of the
arginine and the base at the 1 position, on the same strand as
the hydrogen bonded partner. These types of interactions have
already been identified in other Ets domain DNA complexes
andmay contribute to sequence specificity at this site due to the
fact that arginine-guanine interactions are energetically the
most favorable (61, 62).
The DNA sequences recognized by different subclasses of
the Ets family outside the central GGA core are more diverse
(32, 33). Etv1, Etv4, Etv5, and Fev all belong to the class I sub-
family of Ets domains with a preferred consensus sequence
5-ACCGGAAGT-3. Both Etv1 and Fev display an absolute
requirement for positions1 to3, strong preferences at posi-
tions 1, 2, and 4, and somewhat more relaxed sequence
selectivity at positions 3, 5, and 6 (32). The means by
which this recognition is achieved is not currently well under-
stood, as relatively few direct base contacts outside the core
GGAmotif can be seen in the current structures in the PDB (30,
63–65). From analysis of the high resolution structures of the
Etv5 and Fev DNA complexes (which are high enough resolu-
tion ( 2.0 Å) to reliably locate ordered waters), a number of
additional contacts can be seen, which appear to enable direct
readout of additional base pairs both upstream and down-
stream of the GGA core. The two C-G base pairs at positions
2 and 1 lie close to a highly coordinated network of four
water molecules conserved in both structures and are coordi-
nated by polar contacts to the side chains of Asp-387 (Fev Asp-
99), Ser-390 (Fev Ser-102), Arg-394 (Fev Arg-106), Tyr-412
(Fev Tyr-124), and the phosphate oxygens of the two cytosine
nucleotides at positions 2 and 1. These waters are also
found in conserved positions in the crystal structures of the
DNA complexes of SAP-1 (64) and ELK-1 (65) and form a
hydrogen bond to theN4 of the cytosine at position1 (Fig. 3B,
Fig. 4, A–C). A detailed examination of the chemical environ-
ment of these water molecules using known hydrogen bonding
donors and acceptors as fixed entities (assuming normal proto-
nation states at physiological pH) reveals a single unique
arrangement that satisfies all of the interactions in the network
(Fig. 4D). The requirement in this network for the water closest
to the base at position 1 to be a hydrogen bond acceptor
almost perfectly explains the observed sequence preferences at
TABLE 4
Numbering of equivalent residues in Etv1, -4, and -5 and Fev
Etv1 Etv4 Etv5 Fev
Gln-336 Gln-342 Gln-369 Gln-48
Leu-337 Leu-343 Leu-370 Leu-49
Trp-375 Trp-381 Trp-408 Trp-87
Lys-379 Lys-385 Lys-412 Lys-91
Asp-387 Asp-393 Asp-420 Asp-99
Lys-388 Lys-394 Lys-421 Lys-100
Arg-391 Arg-397 Arg-424 Arg-103
Ser-392 Ser-398 Ser-425 Ala-104
Arg-394 Arg-400 Arg-427 Arg-106
Tyr-395 Tyr-401 Tyr-428 Tyr-107
Tyr-396 Tyr-402 Tyr-429 Tyr-108
Tyr-397 Tyr-403 Tyr-430 Tyr-109
Lys-399 Lys-405 Lys-432 Lys-111
Lys-404 Lys-410 Lys-437 Lys-116
Arg-409 Arg-415 Arg-442 Arg-121
Tyr-410 Tyr-416 Tyr-443 Tyr-122
Cys-416 Cys-422 Cys-449 Phe-F126
FIGURE 2. Interactions of Etv1 with DNA. A, contacts formed by DNA com-
plex crystals. The DNA molecules in the DNA complex crystals associate via
blunt (Etv1 and Fev) or sticky ends (Etv4 and Etv5) with neighboring mole-
cules in the crystal. The contents of the asymmetric unit are colored by chain
with symmetry-related molecules colored gray. DNA fibers ending in dashed
lines form a continuous helix running the entire length of the crystal. B, stereo
view of the interaction between Etv1 and DNA. Etv1 is shown in cartoon
representation with secondary structure elements labeled; residues forming
close contacts with the DNA are shown as sticks, and the DNA is shown in the
line representation. The DNA can be seen to undergo a significant widening
of the major groove to accommodate extensive interactions with residues
from the recognition helix 3. C, schematic view of the residues involved in
the DNA protein interface of both Etv1 (shown on the left) and Fev (shown on
the right). Hydrogen bonds are depicted as solid black lines, and salt bridges
are represented as dashes. D, comparison of the DNA from the Etv1 DNA
complex (black) with canonical B form DNA of similar length (red). The DNA
can be seen to undergo a significant widening of the major groove and bend-
ing of 20° toward the protein interface.
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this position (32), with a strong selection of cytosine (75%
occurrence) and the only other allowed base being adenine
(15% occurrence), which is also able to donate a hydrogen
bond, although in this case the hydrogen bonding distance
would be significantly longer (4.0 Å). The close packing of
these water molecules also appears sufficient to explain the
selectivity at the 2 position (in which cytosine is the most
favored base and thymine is the least frequent), due to the
potential to form favorable van der Waals-type interactions
with the nonpolar face of the cytosine and potentially unfavor-
able interactions or steric clashes with the thymine methyl C7.
This mode of recognition also likely occurs at the 1 position;
consequently, there would be a similar discrimination against
5-methylcytosine, which could occur in position 1 (which is
part of aCpGbase step). Interestingly, one high resolution crys-
tal structure in which the positions of these waters is not con-
FIGURE 3. Molecular basis of DNA sequence recognition. A, stereo view of the sequence-specific protein DNA interactions between Fev and DNA that
facilitate the recognition of the core GGA motif. Key residues and nucleobases are shown in the stick representation, and hydrogen bonds are shown as dotted
lines. B, recognition of features upstream of the GGA core is achieved via a highly coordinated network of water molecules that are conserved among other class
I ETS domains. C, recognition of DNA sequence features downstream of the core GGA motif by the dual conformation of Tyr-107, which appears to be able to
form both polar and nonpolar interactions with the thymine at position 4, and in its alternative conformation it forms van der Waals interactions with
nucleobases at the 4 and 5 positions on the complementary strand from the GGA core.
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served, the PU.1 DNA complex (66), is a member of the class III
subfamily of Ets domains that are specific for EBS sequences con-
taining adenine and guanine in the 1 and 2 positions, respec-
tively (32). The base pairs at positions 4 and 5 downstream
from the GGAmotif lie close to the side chain of Tyr-395, which
has the potential to accept a hydrogen bond from the N6 of the
adenine at position4, and also to forma favorable vanderWaals
interaction with the corresponding thymine C7methyl.
In the Etv5 and Fev DNA complex structures, the corre-
sponding residue (Etv5-Tyr-428 and Fev-Tyr-107, respectively)
can be seen to occupy two conformations, one in which the two
interactions detailed above are conserved, and an additional
conformation where the side chain hydroxyl lies close to Etv5-
Lys-432/Fev-Lys-111 and provides a large contact surface, with
the potential for favorable van der Waals interactions to bases
at positions5 and6 on the complementary strand (Fig. 3C).
As discussed below, mutation of the corresponding tyrosine in
Etv1 (Tyr-395) to phenylalanine had little effect on DNA bind-
ing affinity, suggesting that this van derWaals interaction is the
most significant contribution of this residue to binding energy.
Although these interactions may not be sufficient to determine
the absolute sequence preferences at these positions, the exper-
imentally derived preferences are more relaxed, with a toler-
ance for thymine at4, adenine at5, and cytosine at6 (32).
Both the importance to DNA recognition and the dynamic
nature of this residue have already beendemonstrated in a com-
parative structural study of the DNA binding properties of the
Elk-1 and Sap-1 Ets domains (65) in which a salt bridge, estab-
lished between the nearby Lys (equivalent to Fev-Lys-111) and
a neighboring Asp residue (equivalent to Fev-Asp-110), was
thought to stabilize the tyrosine in its alternative position. The
finding that both conformations of this residue appear to occur
together indicates that the dynamic nature of the side chains of
the recognition helix may be even more important for DNA
recognition than previously thought.
Order-Disorder Transitions upon DNA Binding—A compar-
ison of the structures of Etv1, Etv4, and Fev in the presence and
absence of DNA allows us to identify conformational changes
that may occur upon DNA binding. In both cases, the overall
structure is very well conserved (root mean square deviation of
1Å), with onlyminormovements of both theN andC termini
and the 3-4 loop, which appear tomove away from the DNA
in the DNA complexes of both Etv1 and Fev, avoiding potential
steric overlaps that can be seen to occur following structural
superposition. On an individual residue level, the most striking
transitions can be seen to occur in the recognition helix 3,
where in Etv1 Asp-387, Arg-391, and Arg-394 can be seen to
become ordered upon DNA binding (Fig. 5, A, and B) and Tyr-
395, which can be seen to switch between the two alternative
rotamers found to be important for recognition of bases down-
stream of the GGA motif in the Fev-DNA complex. Similar
transitions occur in the Fev structure where Asp-99, Arg-103
and Tyr-107 adopt different rotamers, and the disordered Arg-
106 and Lys-111 become ordered upon DNA binding. In Etv4,
in addition to three residues Arg-397, Arg-400, and Tyr-401
adopting different rotamers, the C-terminal end of the recog-
FIGURE 4. Cluster of conserved water molecules in the protein DNA interface. A, 2Fo  1Fc electron d.5. B, 2Fo  1Fc electron density map of the Etv5-DNA
complex, contoured at 1.5. C, structural superposition of the Fev (green), Etv5 (blue), SAP-1 (PDB code 1BC8, cyan), and ELK1-DNA (PDB code 1DUX, pink)
complexes showing the conserved positions of the four water molecules important for recognition of bases at the 1 and 2 positions. D, schematic view of
the water network with hydrogen atoms shown explicitly and hydrogen bonds and distances shown in blue. A single arrangement of hydrogen atoms is
sufficient to fulfill all of the required donor-acceptor pairs, and it includes the requirement for a hydrogen bond donor at the 1 position, explaining the
observed substrate specificity at this site.
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nition helix switches from a 310 hydrogen bonding pattern
(which is the form adopted in all the other ETS structures) to a
more canonical -helical hydrogen bonding pattern, although
in this case the difference may be due to the fact an ethylene
glycol molecule is bound in the vicinity (Fig. 5A). The dynamic
nature of the residues within the recognition helix is likely to be
an important factor for Ets domain recognition, and it indicates
possible means whereby Ets domains may scan along the DNA
duplex in search for high affinity sites following binding to non-
specific sites, in a similar manner to that observed for the lac
repressor DNA complex (67).
Biochemical Analysis of Etv1 DNA Binding—To assess the
contribution of individual residues to DNA binding in the solu-
tion we have, using Etv1 as a model system, mutated several
residues individually to alanine or (in the case of tyrosine resi-
dues) to phenylalanine. Isolated Ets domains containing each of
themutations were compared in EMSAs to wild-type Etv1 (Fig.
6A andTable 3).We also compared the Etv-1 construct used for
crystallization, which contains two primer-induced mutations,
against wild-type Etv1 and found no significant difference in
DNA binding (Fig. 6B). Somewhat surprisingly, mutants in res-
idues involved in salt bridges to the DNA backbone (Lys-379
and Lys-404) exhibited no detectable DNA binding. Similarly,
mutants of the tyrosine residues forming hydrogen bonds to the
DNA backbone (Tyr-396 and Tyr-397) to either phenylalanine
or to alanine also resulted in significant (1000-fold) reduction
in binding affinity to DNA.
FIGURE 5. Structural transitions on DNA binding in Fev and Etv1. A, comparison of the apo- and DNA-bound forms of Etv1 (shown on the left), Etv4 (center),
and Fev (shown on the right) reveals significant disorder-order transitions and rotamer movements within the recognition helix that accompany DNA binding.
B, comparison of temperature factors of apo- and DNA-bound forms. The average B-factor (normalized so that the mean value is equal to zero) is plotted as a
function of residue number for Fev (left panel) and Etv1 (right panel), with secondary structural elements shown for reference. Residues belonging to the
recognition helix 3 are highlighted by a gray background and can be seen in both cases to transition from relatively high B-factors to among the lowest
B-factors in the entire structure. These transitions, however, were not seen in a comparison of Etv4 apo- and DNA-bound crystals, probably due to the extensive
crystal contacts formed by residues in this helix in the apo-crystals, which consequently diffract to 1.05 Å resolution.
FIGURE 6. Mutational analysis of Etv1 DNA binding. A, DNA binding iso-
therms of mutated Etv1 proteins derived from EMSAs using the standard DNA
probe at 2 nM. Error bars are plotted as 
 S.E. of replicates. B, comparison of
the DNA binding to WT and the primer-induced mutant Etv1 (Y329S/P427S)
used for crystallization.
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Mutations in individual residues involved in nucleobase
interactions affected DNA binding to a lesser extent. Mutants
of the invariant Arg-391 and Arg-394 bound DNA 50- and
1300-fold less than the wild type, respectively. Interestingly,
mutation of Tyr-395 to phenylalanine did not affect the Kd val-
ues, but maximal DNA binding at saturation was only 60% of
the total probe; this may indicate a rapid dissociation (high koff)
of the complexes. Uniquely among the residues tested, aD387A
mutation had no effect on DNA binding; it is possible that this
residue contributes little to the free energy of binding to the
cognate DNA sequence but may be crucial for selectivity (see
below). Overall, the mutational analysis demonstrates that the
residues interacting with the DNA backbone in the crystal
structure are the major contributors to the binding affinity in
solution, although the interactions with the bases add a signif-
icant but lower energetic contribution.
Biochemical Analysis of Etv1 Binding to Methylated DNA—
To test whether CpGmethylation directly affects Etv1 binding,
we modified the 20-bp oligonucleotides used in the EMSA
experiments by substituting 5meC at position 1 of the con-
sensus (CGGAA) along with the cytosine complementary to
G1, generating a fully methylated CpG motif (CmGGAA/
TTCCmG). EMSA experiments showed that the Etv1 protein
failed to bind themethylatedDNA (Fig. 7A).Modeling of 5meC
at these positions in the Etv1-DNA and Fev-DNA structures
(Fig. 7B) showedArg-394/106 (Etv1/Fev)was close to the 5meC
at 1 of the CGGAA consensus strand, and Asp-387/99 was
close to 5meC at both 1 of the CGGAA strand and 1 on the
complementary strand. Methylation of cytosines at these posi-
tions could create a steric clash with Arg-394/106 causing loss
of hydrogen bonds involved in the conserved water network.
EMSA analyses of Etv1D387A and Etv1R394A mutants showed
that replacement of either of these charged side chains with the
smaller and hydrophobic alanine recovered some binding to
methylatedDNA (3 and 2%of totalDNAbound, respectively, at
the highest protein concentration) compared with the wild-
type protein (Fig. 7A). It may be significant that Asp-387 (or
glutamate) is almost invariant in the ETS recognition helix,
with only class III proteins displaying a substitution to gluta-
mine (32). As class I Ets proteins predominantly select cytosine
at the1 position of the consensus, although class III members
typically have adenine (32), it is possible that Asp-387 (or Glu)
plays a universal role not only in the preference for cytosine at
1 but also to the discrimination against CpG-methylated
sites.
Direct Regulation of DNABinding by PKA Phosphorylation of
the Etv1 Ets Domain—Ets proteins are regulated by phosphor-
ylation (68); for example, the protein kinases RSK1 and PKA
phosphorylateEtv1atmultiplepositions in vivo (40). PKAphos-
phorylation of Etv1 Ser-334 (at the N-terminal edge of the Ets
domain) inhibits in vitroDNAbinding of the full-length protein
but increases transcriptional transactivation potential, as does
FIGURE 7. Effects of methylation and phosphorylation on Etv1 DNA binding. A, representative EMSA analysis of three Etv1 proteins (wild type, D387A, and
R394A) titrated against normal (upper panel) and 5meC-modified DNA (Etv1ALF-5meC/Etv1ALR-5meC, lower panel). Gradients represent increasing protein
concentrations, and unbound DNA substrate and complexes are marked. B, model of potential interactions with 5-methylated cytosine, based on the Fev-
dsDNA structure (PDB code 3ZP5) with methyl groups on the methylated cytosines shown in green, and a conserved water molecule shown in purple. C,
representative EMSA analysis of wild type (left panel), S334E phosphorylation mimic (right), and PKA-phosphorylated Etv1 (center panel) titrated against normal
DNA substrate. The DNA binding isotherms derived from these data are plotted below. D, model of potential clashes between phosphorylated Etv1 Ser-334 in
the Etv1-dsDNA structure (PDB code 4BNC) superimposed onto a longer dsDNA from PU.1-dsDNA (PDB code 1PUE). Distances between potentially clashing
atoms are shown as green dashed lines.
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phosphorylation of the equivalent Ser-367 in Etv5 (41). In con-
trast, Etv4 lacks a serine at the equivalent position (asterisk, Fig.
1A). To assess whether Ser-334 phosphorylation of the Ets
domain affects DNA binding directly, we phosphorylated Etv1
with PKA on Ser-334 in vitro (Fig. 7, C and D). In parallel, we
produced a phosphomimetic mutant of Ser-334 to glutamate.
EMSA experiments showed that phosphorylation of Ser-334
reduced the binding affinity by at least 200-fold (Fig. 7C). This
confirms that Ser-334 phosphorylation can directly interfere
with DNA binding of the Etv1 Ets domain, independent of
other regions of Etv1 or of other proteins (40). Interestingly, the
S334Emutation caused only a modest reduction in the binding
constant, but overall probe binding levels were 35% at appar-
ently saturating DNA concentration. This may indicate a
kinetic instability of DNA binding by the mutant protein. A
phosphoserine residue is bulkier and carries more negative
charge than glutamate, suggesting that the strong effect of the
phosphate is due to charge repulsion. Modeling of a phosphor-
ylated Ser-334 in the Etv1-dsDNA structure (PDB code 4BNC)
superimposed onto a longer dsDNA (Fig. 7D) shows a possible
repulsive interaction between the phosphate on the protein and
the DNA backbone, which may underlie the decrease in DNA
binding.
Etv1/4/5 and Fev Are Disulfide-linked Homodimers—Analy-
sis of the contacts between adjacentmolecules in the Etv1, Etv4,
and Etv5 crystals reveals a conserved potential dimer interface
that is distant from the DNA binding surface and is present in
all the DNA-free and DNA-bound crystal forms (Fig. 8A). This
interface is centered around contributions from the N- and
C-terminal helices, 1 and 4, with additional contacts involv-
ing residues from the 1-2 loop (Fig. 8B). The contact area for
this interface is 800 Å2, includes contributions from 20 resi-
dues, and accounts for the burying of 15% of the monomer
accessible surface area upon complex formation. The majority
of the interface is nonpolar in nature with extensive hydropho-
bic interactions. Similarly, an analysis of the crystal contacts in
FIGURE 8. Overview of the dimerization interfaces. A, view of the potential dimers formed in Etv1 (shown on the left) and Fev (right) DNA complexes with the
2-fold axis vertical, showing the DNA in cartoon representation. The structures of the Etv4 and Etv5 dimers are essentially identical to Etv1. B, close view of the
secondary structural elements and residues that compose the dimer interfaces for Etv1 (left) and Fev (right) with polar contacts depicted as dashed lines. C, 2Fo
 1Fc electron density maps, for Etv1 (left) and Fev (right), both contoured at 1.0  in the vicinity of the intermolecular disulfide bond. Two conformations can
be seen for Cys-416 in the Etv1 structure (also observed in the high resolution structures of Etv4 and Etv5), although it is not clear whether this is induced by
radiation damage or an intrinsic property of this residue.
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both the Fev and Fev-DNA crystals reveals an interface that
includes the same components (1 and 4 and the 1-2 loop)
as that of the other three Etv proteins. However, the dimer
interfaces in Etv1/4/5 and in Fev are not equivalent; rather, they
differ by a relative rotation of 90°, reflecting the different ori-
entations of the 4 helix (Fig. 1C). The contact area for the Fev
dimerization interface is 700 Å2, spans 21 residues, and
accounts for 12.5% of the monomer accessible surface area.
Similar to Etv1, the interface is dominated by contacts from
hydrophobic residues, a single hydrogen bond (Asp-59–His-
72), and an intermolecular disulfide bond betweenCys-135 and
its symmetry mate (Fig. 8, B and C). All the proteins were puri-
fied and crystallized in the presence of reducing agent (1 mM
TCEP), although the reducing agentmay have become oxidized
during crystallization in an oxygen-containing environment.
Intermolecular dimerization has been documented previ-
ously in Ets factors (69), with ETS1 forming head-to-head
homodimers required for cooperative binding on palindromic
and other sites (70). ELK1 dimerization appears to regulate
ELK1 cellular stability (71), with a homotypic interface utilizing
the 1 helix, similar to that of Etv1/Fev, but with a different
positioning and orientation (65). The presence of an intermo-
lecular disulfide bond formed between similar C-terminal
regions Etv1, Etv4, Etv5, and Fev is particularly significant, as
they are homologous to ETS1 that can form disulfide-linked
dimers in vivo (72). Although present in the crystal structures,
disulfide-linked Ets domain dimers were not initially observed
in solution (Fig. 9A).When Etv1, Etv4, or Etv5 was expressed in
Rosetta-gamiTM 2 Escherichia coli (73) and purified under
nonreducing conditions, a peak consistent with the dimer
FIGURE 9. Redox-dependent regulation of Etv1, Etv4, and Etv5. A, purification of Etv1 (left panel), Etv4 (center panel), and Etv5 (right panel) under reducing
(solid lines) or nonreducing conditions (dashed lines). The inset in the left-hand panel shows the SDS-PAGE analysis of the size exclusion fractions denatured in
the presence (upper right) or absence (lower right) of 5 mM DTT. B, nonreducing SDS-PAGE of an SEC fraction of Etv1 eluting as a dimer (WT dimer) or treated prior
to gel loading under various reducing conditions: 10 mM TCEP, and different ratios of reduced (GSH) and oxidized (GSSG) glutathione. C, DNA binding isotherms
of different oligomeric/redox states of Etv1 from EMSA analysis. The proteins used were as follows: Etv1 purified under reducing conditions (monomeric);
Etv1-C416S mutant (monomeric); Etv1 dimer purified under oxidizing conditions; Etv1 dimer treated with 10 mM TCEP; Etv1 dimer treated with reduced
glutathione: and Etv1 dimer treated with oxidized glutathione. D, DNA binding isotherms of Etv4 and Etv5 from EMSA analysis. The proteins used were as
follows: Etv4 purified under oxidized conditions (dimeric); Etv5 purified under oxidized conditions (dimeric); Etv4 dimer treated with 10 mM TCEP; and Etv5
dimer treated with 10 mM TCEP. DNA probe concentration was 0.2 nM. Error bars are plotted as 
 S.E. E, EMSA of dimeric Etv1 showing a slower mobility
Etv1-DNA species that is presumed to represent the dimeric species. F, EMSA of dimeric and reduced Etv5 showing bands representing monomeric and dimeric
DNA complexes. G, EMSA of dimeric and reduced Etv5 showing bands representing monomeric and dimeric DNA complexes.
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molecular weight was observed in size exclusion chromatogra-
phy (Fig. 9A). SDS-PAGE in the presence or absence of DTT
suggests the higher molecular weight peak contained a reduc-
ing agent-sensitive dimer, which was further confirmed by
mass spectrometry. We have been unable to test whether Fev
also forms disulfide-linked homodimers, as our Fev constructs
did not produce soluble protein in the Rosetta-gamiTM 2 E. coli
cells.
Disulfide Bond Formation and Dimerization Inhibit DNA
Binding—Todiscover the functional consequences of disulfide-
dependent dimerization, we compared the DNA binding affin-
ities of purifiedmonomeric and dimeric Etv1 using EMSA. The
reduced monomeric Etv1 protein bound the DNA probe with
an affinity up to 200-fold higher than the oxidized dimeric form
(Table 3; Fig. 9, A and C); a C416S mutant of Etv1 bound DNA
with an affinity similar to the reduced wild-type Etv1 (0.26 nM).
Similarly, dimeric Etv4 and Etv5 also bind DNA with affinities
that are 2 orders of magnitude lower than the reduced mono-
meric forms (Fig. 9, D, F, and G and Table 3; note that the Kd
values of the dimeric forms are rough estimates, as saturation
could not be reached). A graded response to physiological
redox potentials could be seen when Etv1 dimers were treated
with different ratios of reduced and oxidized glutathione; the
extent of DNA binding roughly correlates with increasing the
reducing agent potential and dimer dissociation (Fig. 9, B and
C). We conclude that Etv1, Etv4, and Etv5 binding to DNA is
reversibly inhibited by the formation of a disulfide-linked
dimer.
DNA complexes of dimeric Etv4 and Etv5 migrate at a lower
mobility than complexes of the monomeric proteins (Fig. 9, F
andG), indicating the presence of a dimer of Etv4/5 with one or
two bound probe molecules. EMSA using the dimeric form of
Etv1 results in a band with mobility of a monomer (Fig. 9E); we
assume this reflects the small amount of monomeric protein
that is present in the high molecular weight SEC fractions (Fig.
9B, left lane); this monomeric subpopulation could not be
removed by repeated chromatography. However, at the highest
concentrations of dimeric Etv1 and DNA, a weak slower
migrating band could be observed with a mobility similar to
that of the Etv4 and Etv5 dimeric complexes. The paradoxical
observation of the dimer in complex with DNA in the various
crystal structures may be accounted for by high concentrations
of both protein andDNA (1mM) during crystallization,which
may be well in excess of the dissociation constant.We also note
that both DNA-bound and -unbound forms of the proteins
crystallized in the disulfide-bonded form, perhaps indicating
that the monomeric form is considerably more flexible and dif-
ficult to crystallize.
Discussion
Although the interaction between Ets domains andDNAhas
been the subject of numerous previous structural and biochem-
ical studies (32, 74), the question of how Ets domains are able to
achieve DNA sequence specificity beyond the GGA consensus
motif has remained open. Furthermore, although a variety of
post-translational modifications regulate Ets transcription fac-
tors (39, 40, 75–77), the mechanisms involved have yet to be
unambiguously clarified (8). In particular, it is not known
whethermodification exerts a direct effect on Ets protein-DNA
binding, protein-protein interactions, or stability.
Our structural analysis of the Etv1, Etv4, Etv5, and Fev Ets
domains both in the presence and absence of DNA has allowed
us to identify additional features of the protein-DNA interface.
Mutation of individual residues supports predictions from the
crystal structure for binding the GGA core for most residues
tested. Remarkably, mutating any of the residues of Etv1, which
interact directly with the DNA backbone (Lys-379, Tyr-396,
Tyr-397, and Lys-404), led to complete loss of binding. The
extent to which these substitutions affect the binding affinity
indicates that these residuesmight play a crucial role in opening
the DNA to allow the 3 recognition helix to access the wid-
ened major groove or anchor the Ets domain once recognition
has occurred. Further interface features include the dynamic
nature of a conserved tyrosine (Tyr-395 in Etv1), which may
allow for recognition for up to three bases downstream from
the GGA core. In addition, a conserved cluster of coordinated
watermolecules supports a structural basis for sequence recog-
nition of two bases upstream of the GGA core, including selec-
tivity against thymine as well as 5-methylcytosine bases at posi-
tion1 of the consensusmotif.Methylated basesmay create an
energetically unfavorable environment for conserved aspartate
and arginine residues, preventing Ets proteins from binding
when transcription is to be repressed by CpGmethylation (43),
as observed previously for Ets proteins (44–46). Although dif-
ficult to rule out the role of indirect recognition through
sequence dependence of the DNA bending observed in our
structures, the additional direct and water-mediated interac-
tions seen in the Etv1 and Fev protein-DNA crystal structures
appear to be sufficient to explain almost entirely the observed
sequence specificities.
Etv1 is post-translationally regulated by Rsk1 and PKA phos-
phorylation in vivo (40). We were able to reproduce the inhibi-
tion of DNA binding by specific phosphorylation of Ser-334, a
known PKA target site, in the isolated Ets domain in vitro. This
demonstrates a direct effect of post-translational regulation on
an Ets domain, and our Etv1-DNA structure suggests that an
increase innegativechargearoundSer-334 followingphosphor-
ylation may directly abrogate DNA binding following electro-
static clashes.
Crystal structures of all four Ets domains exhibit disulfide-
linked homodimers. Dimerization of Etv1, -4, and -5 is medi-
ated by the homologous cysteine residues (Cys-416, Cys-422,
and Cys-449, respectively). Fev dimers are linked by a different,
nonconserved cysteine (Cys-135).
We found that disulfide-mediated dimerization strongly
inhibited Etv1, Etv4, and Etv5 DNA binding in vitro, which was
directly reversible with increasing redox potential. Our crystal
structures do not provide an explanation for this inhibition; the
DNA in the crystal is bound to the dimeric protein, and the
dimerization interface is sufficiently distant from the DNA
binding interface to eliminate the possibility of steric effects
with the substrates used (20-mer with the consensus sequence
centrally located). Examination of the protein DNA interfaces
in these crystals and comparison with other active Etv DNA
complexes reveal very similar interfaces, with similar contacts
made to the phosphodiester backbone and themajor sequence-
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specific DNA interactions provided by the recognition helix
being totally conserved (Fig. 10). Thus, we believe the interfaces
in our dimeric crystal structures to be representative of the
higher affinity monomer DNA interface. This leads us to sug-
gest that that the most likely explanation for the inhibition
caused by dimerization is an allostericmechanismof inhibition,
which acts through changes in protein flexibility or dynamics.
The mechanism may be similar to the autoinhibitory mecha-
nism of ETS1, where packing of a 4-helical inhibitory module
also distal to the DNA-binding face allosterically modulates
subtle structural changes that inhibit DNA binding (78). It is
also possible that the constraints of crystallization favor a pro-
tein conformation that is less stable in solution. However,
structural studies of allosteric regulation do not always reveal a
clear-cut mechanism, and there are cases where allosteric reg-
ulation acts through changes in protein flexibility or dynamics
(79–81).
Redox control of transcription factors is a recognized regu-
latory mechanism (80, 82–84). Examples include intermolecu-
lar disulfide bridges in bZIP proteins, such as AP-1 (85), and
cysteines outside theDNA-bindingmotifmediating redox-sen-
sitive dimerization in plant homeodomains (86). Ets proteins
have been implicated in redox signaling in vivo, such as the
oxidative inactivation of GABP by the Hippo pathway (87).
The mechanism of redox-dependent DNA binding inhibition
in Ets factors has remained unclear, as many contain multiple
cysteine residues. Here, we show that a single redox-sensitive
cysteine is sufficient to confer inhibition of DNA binding by
dimerization.
Notably, cysteines at positions equivalent to Etv1-Cys-416
exist in addition only in GABP, ETS1, and ETS2 out of all
human Ets domain proteins. Although dimerization and disul-
fide formation seem to have regulatory influence on proteins,
including GABP (88) and ETS1, the equivalent cysteines in
crystal structures of ETS1, GABP, and ETS2 (89, 90) do not
seem to be involved in intermolecular disulfide bridges. This
indicates that the precise mode of redox regulation seen for
Etv1/4/5 may be restricted to a small subset of the Ets protein
family.
Etv1, -4, and -5 are strongly implicated in cancer (8).Our data
suggest the possibility that redox-mediated dimerization could
link Etv1/4/5 factors to the response of cancer cells to their
microenvironment. If proven, chemoprevention by targeting
such redox-sensitive transcription factors could potentially
deliver novel therapeutic strategies (91).
Protein Data Bank Accession Numbers—Atomic coordinates
and structure factors were deposited in the Protein Data Bank
with accession numbers 4AVP (Etv1), 4BNC (Etv1-DNA),
4CO8 (Etv4), 4UUV (Etv4-DNA), 4UNO (Etv5-DNA), 2YPR
(Fev), and 3ZP5 (Fev-DNA).
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